Search the TGA website
Website results
These results do not include items from TGA's databases, such as the Database of Adverse Event Notifications, the System for Australian Recall Actions and Medicines Shortages Information.
Fully-matching results
-
All alerts
https://www.tga.gov.au/all-alertsASTRAZENECA suxamethonium chloride 100mg/2mL injection BP ampoule - medicine shortage (19 April 2015). ... Counterfeit medicine alert: BiCNU (carmustine for injection) 100mg bottle (23 May 2016).
-
FOI 2291 document 2
https://www.tga.gov.au/sites/default/files/foi-2291-02.pdf25 Feb 2022: back and legs over 4 day period 235397 Gardasil Erythema multiforme; blotchy red rash about 5. ... 236683 Gardasil Rash to upper trunk/back and neck - small pink raised spots, itchy.
-
Gardasil (human papillomavirus vaccine)
https://www.tga.gov.au/alert/gardasil-human-papillomavirus-vaccine24 Jun 2010: In addition to the TGA, both the US Food and Drug Administration (FDA) and the European Medicines Agency (EMEA) have assessed Gardasil as safe and effective. ... Vaccine 2007; 25: 5675-5684. &. &. &. Category:Alert/Advisory, Medicines safety. Tags:human
-
FOI 1417 document 4
https://www.tga.gov.au/sites/default/files/foi-1417-04.pdf30 Apr 2020: 10 Vaccines. 10.1.2 Adverse events to human papilloma virus vaccine (Gardasil). ... On the basis of reports reviewed at this Meeting, ADRAC considered there was no immediate requirement to alert the public to safety issues with Gardasil vaccine.
-
All alerts (sorted by date)
https://www.tga.gov.au/safety-alerts11 March 2022. Updates to supply and patient access for tocilizumab (Actemra) medicines. ... 3 June 2021. Product Defect Alert - child-resistant caps may not function correctly.
-
Gardasil (quadrivalent human papillomavirus vaccine), update 2
https://www.tga.gov.au/alert/gardasil-quadrivalent-human-papillomavirus-vaccine-update-213 May 2015: based on what was reported in clinical trials and the current information provided in the Gardasil Product Information and Consumer Medicine Information. ... Cited 13 February 2015. Category:Alert/Advisory, Medicines safety. Tags:human papillomavirus
-
Enhanced school-based surveillance of acute adverse events following …
https://www.tga.gov.au/sites/default/files/medicine-review-school-based-surveillance-immunisation-with-human-papillomavirus-vaccine.pdf13 May 2015: Gardasil is the HPV vaccine being used in the National HPV Vaccination Program. ... Hence, the AEFI rates reported here are likely to overestimate true rates for Gardasil.
-
Gardasil (quadrivalent human papillomavirus vaccine), update 1
https://www.tga.gov.au/alert/gardasil-quadrivalent-human-papillomavirus-vaccine-update-116 May 2013: The majority of reported adverse events are mild, well-recognised and listed in the Gardasil Product Information and Consumer Medicine Information. ... Drug Safety 2013: 36(4) online DOI 10.1007/s40264-013-0039-5. Category:Alert/Advisory, Medicines safety
-
Australian Public Assessment Report for Human Papillomavirus 9 valent …
https://www.tga.gov.au/sites/default/files/auspar-human-papillomavirus-9-valent-vaccine-170103.pdf12 Jan 2017: PI Product Information. Therapeutic Goods Administration. AusPAR GARDASIL 9, Human Papillomavirus 9-Valent Vaccine. ... No Gardasil 9 related adverse effects occurred except at the site of injection.
-
Australian Public Assessment Report for Human Papillomavirus 9 valent …
https://www.tga.gov.au/sites/default/files/auspar-human-papillomavirus-9-valent-vaccine-170103.docx12 Jan 2017: EMA. European Medicines Agency. EU. European Union. F0. F0 is the parent generation (Filial). ... No Gardasil 9 related adverse effects occurred except at the site of injection.
-
Enhanced school-based surveillance of acute adverse events following …
https://www.tga.gov.au/sites/default/files/medicine-review-school-based-surveillance-immunisation-with-human-papillomavirus-vaccine.docx13 May 2015: Gardasil is the HPV vaccine being used in the National HPV Vaccination Program. ... The International Journal of Risk and Safety in Medicine. 2011; 23: 103-112.
